In a health service struggling with the effects of constrained budgets and staff shortages, it is easy to see how infection prevention might fall down the agenda. But with the inexorable advance of antimicrobial resistance, prevention and control of infectious disease is becoming more important than ever. Following on from productive sessions in London and Manchester, Knowlex invites you to continue the vital process of knowledge exchange in our first event of the new year at The Brewery. Developing the themes of those 2016 exchanges, professionals from across the sphere of healthcare will assemble in February 2017 to hear from experts on various aspects of infection prevention and control, from rapid diagnostics to surgical site infection to antibiotic prescribing practices. And as the dust settles on the final report of the Review on Antimicrobial Resistance, join us as we look to the future, at the ways Jim O’Neill’s key recommendations might be transformed into meaningful action.
Although forecasts are uncertain on the costs of antimicrobial resistance, the impact on our lives and on our healthcare systems is bound to be huge, and those least equipped to deal with the consequences will be worst hit. While the Review on AMR - commissioned to look at the problem from an economic perspective - has now come to an end, the time has now come to act on the specific actions recommended by the team to tackle this global emergency.
Attendees at this Knowlex conference will have the chance to interact with those at the forefront of translating research and recommendations into practice. They will hear of the necessity of building international support behind solutions for the long-term, not only for AMR but for infection prevention and control in a broader sense.
Delegates will learn about the innovations that are leading the fightback against infectious diseases and AMR, including pioneering therapies to disable rather than destroy resistant bacteria and, for example, tackle Clostridium without adverse effects on gut flora. http://www.sheffield.ac.uk/news/nr/skin-infections-treatment-antibiotic-resistance-superbug-1.594339
Although the incidence of MRSA has fallen, a rise in cases of MSSA is highlighting the pitfalls of complacency. Skin and soft tissue infections are now by far the most widely reported sources of MRSA bacteraemia, and a worthy focus of attention. Sepsis, another key talking point, results in the loss of around 31,000 lives and costs NHS England £2 billion every year.
Just as NICE guidelines reinforce the continued importance of hand hygiene, they also aim to ensure that attention to urinary catheters, vascular access devices, and other sources of healthcare associated infections does not slip. And with surgical site infection now the second most common cause of HCAI in Europe as well as the United States, this is just one area where transatlantic knowledge exchange could prove vital.